"Your Partner of Choice and your gate to the Middle East and North Africa (MENA) Pharmaceutical World"


Genpharm Services is a financially sound privately owned company based in the Dubai Science Park (DSP), U.A.E. We provide fast-track Market Access to specialty pharmaceutical companies looking to expand into the Middle East and North Africa (MENA) region. We focus on innovative and orphan drugs in areas of unmet medical needs, rare genetic disorders and autoimmune diseases.

Pharmaceutical Strategic Advice

"We also provide Management Consultancy for companies aiming at expanding directly into this dynamic region of high growth. We advise on strategies, structures and operating business models in line with the respective company priorities and portfolio. "

Pharma outlook in the MENA region: an insider's view

Karim Smaira is co-founder and chief executive of Genpharm Services, a regional market access, and pharmaceutical advisory firm. Speaking with The Pharma Letter from his offices in Dubai, Mr. Smaira offers a particular view into the dynamics shaping the region. He says that: “Although there is an effort to harmonize rules and regulations, the region is still very heterogeneous when it comes to the maturity of the markets, the regulations, the approach to pricing or regulatory approval.”

A Key Learning from the Late Henri Termeer

The Rare Disease community and the Biotechnology industry are still reeling from the untimely death of one of its key founders and drivers, Dr. Henri Termeer. Mr. Karim Smaira laments Biotech pioneer and former Genzyme CEO Henri Termeer in his own words.

Genpharm employees rejoice in Lebanon

Genpharm completed its annual meeting. All employees joined to celebrate 2016’s remarkable achievements, in Lebanon.

Aspire Educational Series: Limb Girdle Muscular Dystrophy- Part 18

Limb-girdle muscular dystrophy (LGMD) is a heterogeneous group of muscular dystrophies characterized by proximal weakness affecting the pelvic and shoulder girdles. Occasionally, the heart (cardiac) and breathing (respiratory) muscles may be affected. The severity, age of onset, and features of limb-girdle muscle dystrophy vary among the many subtypes of this condition and may be inconsistent even within the same family. Onset may occur in childhood, adolescence, young adulthood, or even later. Males and females are affected in equal numbers. LGMD incidence ranges from 1 in 14,500 to 1 in 123,000 individuals.

His Excellency Sheikh Nahyan bin Mubarak Al Nahyan honoring Genpharm for their role in raising awareness on Rare Diseases and for their contribution on Rare Disease Day

His Excellency Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Culture and the development of knowledge, president of the UAE Genetic Diseases Association, honored several specialized experts in rare diseases, as part of the annual Emirates International Award for reducing genetic diseases "rare disease category" in its third session.

Films from around the world addressing the challenges of life with a rare disease.

The Rare Disease Film Festival is a new event showcasing films from around the world which address the challenges of life with a rare disease. It will be held Oct. 3rd, 2017 in Boston, MA. We believe increased awareness can connect patient families, inspire conversations about translation applications of current science, lead to new paths for research and save lives. These films put the often abstract and dire clinical information into the context of real people living their lives.

GENPHARM Services - Your Gateway to the MENA Pharmaceutical Market

We are a specialty pharmaceutical marketing and consulting company, providing our strategic partners with fast and sustainable market access into the MENA (Middle East & North Africa) region, including business development, in-licensing and more. We operate through evidence-based medicine and the highest ethical standards. Our expertise is based on an in-depth knowledge of the pharmaceutical market and the local business culture. Furthermore, our vast experience and the trusted network of partners allow us to deliver market opportunities for specialty, rare disease, biotech, and innovative healthcare organizations.

The MENA region has been experiencing fast economic and sustainable GDP growth. This positive outlook is driven by several factors providing pharmaceutical companies with untapped regional opportunities...
The healthcare sector in the MENA region has been experiencing sustainable double digit growth. Driven by unmet medical needs and increased medical public awareness, governments have been heavily investing in both infrastructure and access
We operate through a holistic market approach. We manage all relevant stakeholders for our partners, including Physicians, Patient groups, distributors and payers. Our expertise include KOL management, advocacy and CME programs..
Genpharm Services is managed by highly experienced Pharma executives. The operations are led by staff with a strong track record in senior leadership roles in multinational pharmaceutical organizations...